Adjuvant Therapy of Breast Cancer: Cancer Treatment and Research, cartea 60
Editat de I. Craig Hendersonen Limba Engleză Hardback – 31 aug 1992
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1419.94 lei 6-8 săpt. | |
Springer Us – 5 noi 2012 | 1419.94 lei 6-8 săpt. | |
Hardback (1) | 1435.28 lei 6-8 săpt. | |
Springer Us – 31 aug 1992 | 1435.28 lei 6-8 săpt. |
Din seria Cancer Treatment and Research
- 5% Preț: 1103.03 lei
- 5% Preț: 726.32 lei
- 5% Preț: 787.58 lei
- 5% Preț: 1037.93 lei
- 5% Preț: 1032.64 lei
- 5% Preț: 1041.77 lei
- 5% Preț: 917.42 lei
- 5% Preț: 719.02 lei
- 5% Preț: 920.18 lei
- 5% Preț: 472.91 lei
- 5% Preț: 651.84 lei
- 5% Preț: 491.35 lei
- 5% Preț: 721.19 lei
- 5% Preț: 370.38 lei
- 15% Preț: 700.10 lei
- 5% Preț: 2116.84 lei
- 5% Preț: 1414.08 lei
- 5% Preț: 1424.16 lei
- 5% Preț: 1106.69 lei
- 5% Preț: 1297.62 lei
- 5% Preț: 1103.22 lei
- 5% Preț: 1094.44 lei
- 5% Preț: 1096.45 lei
- 5% Preț: 1413.56 lei
- 5% Preț: 720.10 lei
- 5% Preț: 706.77 lei
- 5% Preț: 731.07 lei
- 5% Preț: 1414.80 lei
- 5% Preț: 1108.72 lei
- 5% Preț: 1098.12 lei
- 5% Preț: 1092.22 lei
- 5% Preț: 1099.56 lei
- 5% Preț: 1106.33 lei
Preț: 1435.28 lei
Preț vechi: 1510.81 lei
-5% Nou
Puncte Express: 2153
Preț estimativ în valută:
274.69€ • 286.02$ • 232.14£
274.69€ • 286.02$ • 232.14£
Carte tipărită la comandă
Livrare economică 10-24 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780792316565
ISBN-10: 0792316568
Pagini: 464
Ilustrații: XVI, 464 p.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 1.05 kg
Ediția:1992
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
ISBN-10: 0792316568
Pagini: 464
Ilustrații: XVI, 464 p.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 1.05 kg
Ediția:1992
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I. Rationale and Methods for Studying Adjuvant Systemic Therapy.- 1. Evolving concepts in the adjuvant systemic therapy of operable breast cancer.- 2. Statistical methods for early breast cancer trials.- II. Results of Clinical Studies.- 3. The nature of the benefit.- 4. Adjuvant endocrine therapy of breast cancer.- 5. Adjuvant chemotherapy of axillary lymph-node-positive breast cancer.- 6. The node-negative problem: To treat or not to treat.- III. Special Problems.- 7. Defining the high-risk breast cancer patient.- 8. Models for weighing benefits and toxicities.- 9. Financial considerations in the use of adjuvant chemotherapy.- 10. The use of adjuvant therapy in patients treated with conservative surgery and radiotherapy.- 11. Treating the relapsed patient.- IV. Future Directions.- 12. Unanswered questions in the adjuvant therapy of breast cancer.- 13. Neoadjuvant chemotherapy.- 14. Altering cell kinetics with endocrine therapy.- 15. Polypeptide growth factors: Their potential value in the management of breast cancer patients.- 16. Immunotherapy of breast cancer.- 17. Breast cancer chemoprevention.- Appendices.- I. Consensus statements from panels convened by The National Cancer Institute in 1980, 1985, 1990.- II. List of completed and ongoing randomized clinical trials addressing questions related to the use of adjuvant systemic therapy to treat resectable breast cancer.
Recenzii
'Overall, this book is a useful review Volume containing thoughtful and up-to-date information on the optimal use of adjuvant therapy for breast cancer. It will be a valuable addition to the library of the practicing clinical oncologist.' Journal of the Nat. Cancer Inst. 85:10 1993